Stockreport

GoodRx Reports Fourth Quarter and Full Year 2025 Results

GoodRx Holdings, Inc. - Class A  (GDRX) 
PDF Fourth Quarter and Full Year 2025 Revenue and Adjusted EBITDA Results In-line with Previous GuidancePharma Direct Revenue Beats Previous Outlook with Over 40% Year-Over- [Read more]